Lv1
80 积分 2023-08-31 加入
Radiotherapy, immunity, and immune checkpoint inhibitors
1个月前
已完结
High-dose hyperfractionated simultaneous integrated boost radiotherapy versus standard-dose radiotherapy for limited-stage small-cell lung cancer in China: a multicentre, open-label, randomised, phase 3 trial
1个月前
已完结
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
1个月前
已完结
Lung cancer
2个月前
已完结
The present and future of bispecific antibodies for cancer therapy
2个月前
已完结
Bispecific antibody platforms for cancer immunotherapy
2个月前
已完结
Opportunities and challenges of bi-specific antibodies
2个月前
已完结
Trends and Challenges in Bispecific Antibody Production
2个月前
已完结
The emerging role of local therapy in oligometastatic non–small cell lung cancer
2个月前
已完结
Oligometastasis: Past, Present, Future
2个月前
已完结
皖公网安备34019202002308
